BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shigayeva A, Rudnick W, Green K, Tyrrell G, Demczuk WH, Gold WL, Gubbay J, Jamieson F, Plevneshi A, Pong-Porter S, Richardson S, McGeer A; Toronto Invasive Bacterial Diseases Network. Association of serotype with respiratory presentations of pneumococcal infection, Ontario, Canada, 2003-2011. Vaccine 2016;34:846-53. [PMID: 26602266 DOI: 10.1016/j.vaccine.2015.11.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Di Pasquale M, Aliberti S, Azzari C, Moriondo M, Nieddu F, Blasi F, Mantero M. Serotypes and antibiotic susceptibility of Streptococcus pneumoniae isolated from hospitalized patients with community-acquired pneumonia in Italy. SAGE Open Med 2017;5:2050312117720058. [PMID: 28781877 DOI: 10.1177/2050312117720058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
2 Pick H, Daniel P, Rodrigo C, Bewick T, Ashton D, Lawrence H, Baskaran V, Edwards-Pritchard RC, Sheppard C, Eletu SD, Rose S, Litt D, Fry NK, Ladhani S, Chand M, Trotter C, McKeever TM, Lim WS. Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013-18. Thorax 2020;75:38-49. [PMID: 31594801 DOI: 10.1136/thoraxjnl-2019-213725] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
3 Danis K, Varon E, Lepoutre A, Janssen C, Forestier E, Epaulard O, N'guyen Y, Labrunie A, Lanotte P, Gravet A, Pelloux I, Chavanet P, Levy-Bruhl D, Ploy MC, Gaillat J; SIIPA Group . Factors Associated With Severe Nonmeningitis Invasive Pneumococcal Disease in Adults in France. Open Forum Infect Dis 2019;6:ofz510. [PMID: 31868865 DOI: 10.1093/ofid/ofz510] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
4 LeMeur JB, Lefebvre B, Proulx JF, De Wals P. Limited impact of pneumococcal vaccines on invasive pneumococcal disease in Nunavik (Quebec). Can J Public Health 2019;110:36-43. [PMID: 30341482 DOI: 10.17269/s41997-018-0138-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
5 Wijayasri S, Hillier K, Lim GH, Harris TM, Wilson SE, Deeks SL. The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017. PLoS One 2019;14:e0226353. [PMID: 31834926 DOI: 10.1371/journal.pone.0226353] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
6 Cheng MP, Bogoch II, Green K, Plevneshi A, Rudnick W, Shigayeva A, McGeer A, Lee TC; Toronto Invasive Bacterial Diseases Network. Factors Associated With 30-Day Mortality Rate in Respiratory Infections Caused by Streptococcus pneumoniae. Clin Infect Dis 2018;66:1282-5. [PMID: 29140429 DOI: 10.1093/cid/cix999] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Desai S, Policarpio ME, Wong K, Gubbay J, Fediurek J, Deeks S. The epidemiology of invasive pneumococcal disease in older adults from 2007 to 2014 in Ontario, Canada: a population-based study. CMAJ Open 2016;4:E545-50. [PMID: 27730119 DOI: 10.9778/cmajo.20160035] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
8 Azzari C, Serranti D, Nieddu F, Moriondo M, Casini A, Lodi L, de Benedictis FM, De Vitis E, Cavone F, Cortimiglia M, Indolfi G, Lombardi E, Carloni I, Cutrera R, Lucenteforte E, Resti M, Ricci S. Significant impact of pneumococcal conjugate vaccination on pediatric parapneumonic effusion: Italy 2006-2018. Vaccine 2019;37:2704-11. [PMID: 30981627 DOI: 10.1016/j.vaccine.2019.04.012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
9 Kohler PP, Melano RG, Patel SN, Shafinaz S, Faheem A, Coleman BL, Green K, Armstrong I, Almohri H, Borgia S, Borgundvaag E, Johnstone J, Katz K, Lam F, Muller MP, Powis J, Poutanen SM, Richardson D, Rebbapragada A, Sarabia A, Simor A, McGeer A; Toronto Invasive Bacterial Diseases Network (TIBDN). Emergence of Carbapenemase-Producing Enterobacteriaceae, South-Central Ontario, Canada1. Emerg Infect Dis 2018;24:1674-82. [PMID: 30124197 DOI: 10.3201/eid2409.180164] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
10 Mantero M, Aliberti S, Azzari C, Moriondo M, Nieddu F, Blasi F, Di Pasquale M. Role of Streptococcus pneumoniae infection in chronic obstructive pulmonary disease patients in Italy. Ther Adv Respir Dis 2017;11:403-7. [PMID: 28854845 DOI: 10.1177/1753465817728479] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
11 Domínguez A, Soldevila N, Toledo D, Godoy P, Torner N, Force L, Castilla J, Mayoral JM, Tamames S, Martín V, Egurrola M, Sanz F, Astray J; Project Pi12/02079 Working Group. Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study. Hum Vaccin Immunother 2016;12:1891-9. [PMID: 27064311 DOI: 10.1080/21645515.2016.1149661] [Cited by in F6Publishing: 10] [Reference Citation Analysis]